Dr. Beate Mueller-Tiemann
Chief Technology Officer

Dr. Beate Mueller-Tiemann is proud to say her career has reflected whole pharma value chain from early target discovery, lead generation, lead optimization, cell line development, chemical manufacturing and control (CMC) production and commercial manufacturing for both Biologics and Synthetic Molecule therapeutics.

She applies her extensive experience in building R&D pipelines and her unapologetic optimism in science and technology to her leadership, as her teams create and bring high-quality products and innovative manufacturing processes closer to patients in need

Beate joined Cytiva in early 2023, having most recently created and led Sanofi’s Global Manufacturing Science, Analytics and Technology Organization for General Medicines Products. She also headed the Synthetic Molecules CMC organization and iCMC (integrated CMC Project Management) for the Sanofi Biologics and Synthetics Molecule pipeline. Her teams led important global launches of new products. Throughout her seven years at Sanofi, Beate has been recognized for building high performing teams that embrace change, innovation, and future challenges. Beate made a special mark in Sanofi with Digitalization of the full Sanofi CMC operations for all geographies, businesses and modalities enabling the Digital Continuum between R&D and Commercial Manufacturing.

Before Sanofi, she served in senior leadership roles at Bayer Healthcare in Cell and Protein Sciences in Wuppertal, Germany, for nearly nine years where Beate built from scratch a cutting-edge Biologics Drug Discovery team including high end Protein Engineering and Automation capabilities thanks to the integration the former Direvo Biotech. Before moving to Wuppertal, the “birthplace” of aspirin, she spent another nine years with Schering AG in Berlin, which today is Bayer Pharma.

With all the passion for science and technology, Beate never forgets the human side of her teams and is appreciated for her empathy and people orientation. A former athlete who held the 800-meter record from at Fort-Le-Boeuf school district for decades, she believes in setting the pace and measuring performance. She finds inspiration in her diverse teams, when she sees the power of differing perspectives, experiences, opinions, and ideas being unleashed.

Beate earned her PhD at the Heinrich-Pette-Institute in Hamburg, Germany in the field of Molecular Oncology. She holds master’s degrees in biology and Biochemistry from the University of Bielefeld, Germany, and the University of Montpellier in France. She performed her master’s thesis in the field of Molecular Neurology at the former Sandoz, today Novartis, in Basel, Switzerland.

Beate is an elected member of the Board of the Dechema, German Society for Chemical Engineering and Biotechnology and has been active for 18 years in the Cell Culture and the Biotransformation working groups. Beate engages herself to support female talents with mentoring programs and is a member of FiDAR, an association that works towards increasing the representation of women on German corporate boards.

She is based in Frankfurt, Germany.